ArticlePain2026
Kidney and brain-expressed protein upregulation in the anterior cingulate cortex mediates chronic post-thoracotomy pain by the phospho-protein kinase Mζ/glutamate receptor 1 signaling pathway and neuroinflammation in male rats.
Article in Pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
abstractChronic post-thoracotomy pain (CPTP), affecting approximately 50% of patients after thoracotomy, poses a substantial socioeconomic burden with an unclear mechanism. This study investigated the role of kidney and brain-expressed protein (KIBRA) in the contralateral anterior cingulate gyrus (ACC)-a key pain processing region-in a male rat model of CPTP. We found that KIBRA mediates CPTP generation by activating the phosphorylated protein kinase Mζ (p-PKMζ)/glutamate receptor 1 (GluR1) pathway and promoting neuroinflammation. Local application of KIBRA short hairpin RNA in the ACC alleviated postoperative pain, reduced the mechanical hyperalgesia ratio (from 50% to 38%), and downregulated expression of KIBRA, p-PKMζ, GluR1, tumor necrosis factor-α, and interleukin-1β in the ACC neurons. Conversely, ACC overexpression of KIBRA recapitulated CPTP, inducing chest wall hyperalgesia (∼60%) and enhancing the aforementioned pathway and inflammatory markers. Notably, KIBRA overexpression increased CPTP incidence to 100% in thoracotomy rats, with elevated levels of KIBRA, p-PKMζ, GluR1, tumor necrosis factor-α, and interleukin-1β compared with CPTP alone. Administration of the PKMζ inhibitor zeta inhibitory peptide alleviated pain induced by both thoracotomy and KIBRA overexpression. Patch-clamp recordings revealed that zeta inhibitory peptide inhibited the amplitude of evoked excitatory postsynaptic currents (EPSCs) and the frequency of miniature EPSCs in CPTP and KIBRA overexpression groups. These results demonstrate that KIBRA in ACC neurons significantly contributes to CPTP by p-PKMζ/GluR1 and neuroinflammation, offering novel mechanistic insights. However, as the study was conducted exclusively in male animals, and studies in clinical settings have shown that the CPTP prevalence is higher among females, the findings primarily apply to males, underscoring the need for future sex-specific investigations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.